Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TransCatheter Aortic Valve Implantation and Fractional Flow Reserve-Guided Percutaneous Coronary Intervention Versus Conventional Surgical Aortic Valve Replacement and Coronary By-Pass Grafts for Treatment of Patients with Coronary MultiVessel Disease and Aortic Valve Stenosis

NCT03424941 is registered in ClinicalTrials.gov with Maatschap Cardiologie Zwolle as lead sponsor.

NCT NCT03424941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03424941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TransCatheter Aortic Valve Implantation and Fractional Flow Reserve-Guided Percutaneous Coronary Intervention Versus Conventional Surgical Aortic Valve Replacement and Coronary By-Pass Grafts for Treatment of Patients with Coronary MultiVessel Disease and Aortic Valve Stenosis
Lead sponsor
Maatschap Cardiologie Zwolle
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2018
Completion date
June 26, 2024
Enrollment
172 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

aortic stenosis, cabg, fractional flow reserve, multi vessel coronary artery disease, pci, tavi